Trial in progress

HS-20093 against chemotherapy after first treatment

HS-20093 phase 3 · Hansoh · 494 people planned · Registered completion December 2030

Not yet openRegistered completion December 2030

What is being tested

HS-20093, an antibody-drug conjugate aimed at B7-H3, against standard single-drug chemotherapy.

Why it matters

The latest-finishing of the B7-H3 drug trials in this cancer.

ClinicalTrials.gov record ↗ ← Back to the outlook

Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.